STOCK TITAN
  1. Home
  2. News
  3. SMLR

Semler Scientific Inc - SMLR STOCK NEWS

Welcome to our dedicated news page for Semler Scientific (Ticker: SMLR), a resource for investors and traders seeking the latest updates and insights on Semler Scientific.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Semler Scientific's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Semler Scientific's position in the market.

News
Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
Rhea-AI Summary
Semler Scientific, Inc. (Nasdaq: SMLR) will report Q1 financial results on May 7, 2024. The call will be hosted by CEO Doug Murphy-Chutorian, along with CFO Renae Cormier and COO Jennifer Oliva-Herrington. Participants can pre-register for the conference call to receive immediate access details.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.16%
Tags
conferences earnings
-
News
Semler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results
Rhea-AI Summary
Semler Scientific, Inc. (SMLR) reports strong financial results for Q4 and full year 2023 with revenue and net income growth. The company's focus on QuantaFlo® boosts sales. Key figures include Q4 revenues of $15.1 million, a 9% increase, and full year revenues of $68.2 million, a 20% rise. Net income for Q4 was $4.2 million, up by 31%, and full year net income reached $20.6 million, a 44% increase. Cash balance grew to $57.3 million. The company plans to seek FDA clearance for expanded product use.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.89%
Tags
earnings
-
News
Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024
Rhea-AI Summary
Semler Scientific, Inc. (SMLR) will report financial results for Q4 and full year 2023 on March 5, 2024. The CEO will host a conference call with the CFO and COO. Participants can pre-register for the call. Internet and phone dial-in options are available for joining the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.66%
Tags
conferences earnings
News
Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results
Rhea-AI Summary
Semler Scientific, Inc. (Nasdaq: SMLR) reported Q3 2023 highlights, including revenue of $16.3 million, a 16% increase from 2022, and net income of $5.5 million, a 50% increase from 2022. The company also reported quarter-ending cash, cash equivalents, and short-term investments of $56.0 million. Major accomplishments include continued year-over-year quarterly revenue growth and pre-tax net income growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.03%
Tags
earnings
-
News
Semler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023
Rhea-AI Summary
Semler Scientific, Inc. will report financial results for Q3 and first nine months of 2023 on November 9, 2023. CEO Doug Murphy-Chutorian will host a conference call at 4:30 pm ET. Participants can pre-register for the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.52%
Tags
conferences earnings
-
News
Semler Scientific to Present at Upcoming Investor Conference
Rhea-AI Summary
Semler Scientific, Inc. CFO to participate in Lake Street Capital Markets conference on September 14, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.02%
Tags
conferences
News
Semler Scientific Reports Second Quarter and First Half of 2023 Financial Results
Rhea-AI Summary
Semler Scientific reports Q2 revenue of $18.6M, up 25% YoY, with net income of $5.9M, up 44% YoY. Cash, cash equivalents, and short-term investments at $51.8M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.86%
Tags
earnings
-
News
Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023
Rhea-AI Summary
Semler Scientific, Inc. will report financial results for Q2 2023 on August 10, 2023. A conference call will be hosted by CEO Doug Murphy-Chutorian and CFO Renae Cormier at 4:30 pm ET. Participants can pre-register for the call using the provided link. Callers without internet access can join by dialing specified numbers. The call will be archived on Semler Scientific's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
conferences earnings
-
News
Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.94%
Tags
management
News
Semler Scientific to Join the Russell 2000® and 3000® Indexes
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Stock SMLR logo
Semler Scientific Inc

Nasdaq:SMLR

SMLR Rankings

#3833 Ranked by Market Cap
#4059 Ranked by Stock Gains
N/A Ranked by Dividends

SMLR Stock Data

194.34M
5.53M
22.23%
52.88%
3.08%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
San Jose

About SMLR

semler scientific, inc. is an emerging medical risk-assessment company whose diagnostic and testing products and services help to guide patient care and close the gap between cost of care and compensation for care. semler closed the initial public offering of its common stock on february 26, 2014 and its common stock is now listed under the ticker symbol "smlr."​ additional information about semler can be found at www.semlerscientific.com.